Tag: #C.diff

Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease

Fecal Microbiota, live-jslm may be an effective means of preventing Clostridiodes difficile infections in patients with inflammatory bowel disease

bySimon Panand1 others

February 4, 2025

1. The use of fecal microbiota, live-jslm (RBL; REBYOTA®) in the prevention of recurrent Clostridioides difficile infection (rCDI) in patients ...

#VisualAbstract: Prevalence of toxigenic and non-toxigenic asymptomatic Clostridioides difficile colonization in pediatric populations

byMinjee Kim

August 11, 2021

1. Asymptomatic Clostridioides difficile occurred in non-toxigenic strains in 41% and toxigenic strains in 14% of 6 – 12-months-olds. Non-toxigenic C difficile was least ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result